The risk factors, genetic and environmental including obesity, sedentary lifestyle, smoking, alcohol consumption, and diet have been considered to be a major reason of the alarming rise in T2DM worldwide and are the focus of therapeutic targeting to alleviate impaired insulin secretion and IR [9,10]. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.